Pharma Equity Group A/S Cl A Tangible Net Worth Ratio
Pharma Equity Group A/S Cl A tangible net worth ratio. Pharma Equity Group A/S Cl A (PEG) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets (Dkr0.00) from net assets (Dkr25.47 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Pharma Equity Group A/S Cl A to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Pharma Equity Group A/S Cl A (2008–2025)
Tangible net worth ratio of Pharma Equity Group A/S Cl A from 2008 to 2025. This chart shows how Pharma Equity Group A/S Cl A's Tangible Net Worth Ratio has changed across 17 annual periods from 2008 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of Dkr25.47 Million with intangible assets of Dkr0.00 DKK.
Pharma Equity Group A/S Cl A Tangible Net Worth Ratio by Year (2008–2025)
Pharma Equity Group A/S Cl A tangible net worth ratio by year from 2008 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Pharma Equity Group A/S Cl A from 2008 to 2025, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Pharma Equity Group A/S Cl A.
| Year | Tangible NW Ratio | Net Assets (DKK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | Dkr25.47 Million | Dkr0.00 | Dkr38.90 Million | ▲ +0.0 pp |
| 2024 | 100.0% | Dkr48.88 Million | Dkr0.00 | Dkr65.61 Million | ▲ +53.7 pp |
| 2023 | 46.3% | Dkr25.33 Million | Dkr13.60 Million | Dkr67.74 Million | ▼ -53.6 pp |
| 2022 | 100.0% | Dkr46.05 Million | Dkr13.86K | Dkr71.07 Million | ▼ 0.0 pp |
| 2021 | 100.0% | Dkr42.57 Million | Dkr0.00 | Dkr63.65 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Dkr34.28 Million | Dkr0.00 | Dkr57.58 Million | ▲ +0.0 pp |
| 2019 | 100.0% | Dkr67.16 Million | Dkr0.00 | Dkr80.84 Million | ▲ +0.0 pp |
| 2018 | 100.0% | Dkr77.57 Million | Dkr0.00 | Dkr80.84 Million | ▲ +0.0 pp |
| 2017 | 100.0% | Dkr85.09 Million | Dkr0.00 | Dkr86.30 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Dkr96.78 Million | Dkr0.00 | Dkr125.75 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Dkr99.53 Million | Dkr0.00 | Dkr126.25 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Dkr97.95 Million | Dkr0.00 | Dkr123.97 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Dkr36.39 Million | Dkr0.00 | Dkr503.85 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Dkr79.67 Million | Dkr0.00 | Dkr507.76 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Dkr53.06 Million | Dkr0.00 | Dkr497.26 Million | ▲ +0.0 pp |
| 2009 | 100.0% | Dkr53.47 Million | Dkr0.00 | Dkr75.70 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Dkr56.25 Million | Dkr0.00 | Dkr261.67 Million | — |